CGM Accuracy Study in People on Icodextrin Dialysis
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests how well a continuous glucose monitor (CGM) works in people with diabetes who are also using a special dialysis fluid called icodextrin. The goal is to see if the CGM gives accurate readings while on this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes for at least 3 months.
- You've been on peritoneal dialysis (PD) for at least 2 months.
- You are using icodextrin PD solution for at least 1 month (or will switch to it within 3 months).
- Your age is between 18 and 75 years old.
- You are not pregnant, nursing, or planning pregnancy during the study.
- You have not been using a real-time continuous glucose monitor (CGM) regularly in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a continuous glucose monitor to track blood sugar levels in people with diabetes who are on peritoneal dialysis. It may help improve diabetes management during dialysis.
This trial tests using a continuous glucose monitor to track blood sugar levels in intensive care patients. The monitor sends readings wirelessly, which may help doctors adjust insulin more quickly and safely.
This study tests if using a continuous glucose monitor (a sensor that checks your sugar levels all day) can improve blood sugar control in people with type 2 diabetes and kidney disease. You may join if your kidneys are at stage 3 or 4 (not on dialysis or transplant) and you take insulin.
This study tests if a continuous glucose monitor (CGM) can help guide insulin drip therapy for non-ICU patients who are on steroids and specialized nutrition. It aims to make insulin management easier and more accurate for patients with diabetes or high blood sugar during hospitalization.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This trial studies how much of a dialysis fluid called icodextrin stays in your body after one or two doses. It is for people on long-term peritoneal dialysis who are stable and can follow a specific daily schedule.
Hear when a new Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.